Mixed function oxidation and intermediary metabolism: metabolic interdependencies in the liver

Area of Science:

• Biochemistry
• Cellular Metabolism
• Drug Metabolism

Background:

• Hepatic lipogenesis and gluconeogenesis are crucial metabolic pathways in the liver.
• Mixed-function oxidation is a key drug-metabolizing process.
• The interplay between drug metabolism and cellular biosynthesis is not fully understood.

Purpose of the Study:

• To investigate the interaction between hepatic lipogenesis, gluconeogenesis, and drug metabolism.
• To elucidate the role of substrates for mixed-function oxidation in regulating these pathways.
• To determine the factors limiting the rate of mixed-function oxidation in intact liver cells.

Main Methods:

• Studied the effects of aminopyrine and its metabolite, aminophenylpyrazolone, on liver cell metabolism.
• Utilized phenobarbital pretreatment to induce drug-metabolizing enzymes.
• Measured rates of lipogenesis, gluconeogenesis, and mixed-function oxidation under various metabolic conditions.

Main Results:

• Substrates for mixed-function oxidation, like aminopyrine, inhibited both lipogenesis and gluconeogenesis.
• These inhibitory effects were inducible with phenobarbital and absent with aminophenylpyrazolone.
• Competition for cytosolic NADPH and diversion of intermediates were identified as mechanisms for inhibition.

Conclusions:

• An interaction exists between drug metabolism and hepatic biosynthesis in intact liver cells.
• NADPH availability is a critical factor influencing both drug metabolism and cellular biosynthesis.
• The supply of NADPH is likely the rate-limiting step for mixed-function oxidation in the liver under specific conditions.